SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-032962
Filing Date
2020-07-22
Accepted
2020-07-21 18:07:05
Documents
5
Period of Report
2020-07-21

Document Format Files

Seq Description Document Type Size
1 6-K lmnl-6k_20200716.htm 6-K 24416
2 EX-99.1 lmnl-ex991_8.htm EX-99.1 45198
3 EX-99.2 lmnl-ex992_9.htm EX-99.2 53772
4 GRAPHIC grivwbx4srgo000001.jpg GRAPHIC 38195
5 GRAPHIC g1ajumk05ua0000001.jpg GRAPHIC 38195
  Complete submission text file 0001564590-20-032962.txt   229967
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 201039756
SIC: 2834 Pharmaceutical Preparations